课题基金 / 基金详情

Mechanisms Regulating Human NK Cell Cytotoxicity

Mechanisms Regulating Human NK Cell Cytotoxicity
人类 NK 细胞细胞毒性的调节机制
批准号:
9919370
负责人:
DANIEL D BILLADEAU
金额:
$39.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-17 至 2022-04-30

项目摘要

项目成果

DANIEL D BILLADEAU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
NK cells are a subpopulation of lymphocytes whose unique receptors facilitate the detection of infected, transformed, or `stressed' cells. This immune recognition subsequently leads to the development of NK cell- mediated cytotoxicity or the generation of cytokines and chemokines that activate other components of the immune system. Patients with hyper-IgE syndrome (HIES) have immune dysregulation and can be affected by recalcitrant cutaneous herpes virus and papillomavirus infections. A major genetic abnormality found in these patients is deletion or loss-of-function mutations in the gene encoding Dedicator of Cytokinesis 8 (DOCK8), a guanine nucleotide exchange factor (GEF) for Cdc42. The high incidence of recurrent cutaneous viral infections in DOCK8-deficient patients is suggestive of defects in natural killer (NK) cell function. In fact, others and we have recently shown that NK cells deficient in DOCK8 have reduced lytic function, decreased adhesion, F-actin accumulation at the cytotoxic synapse and an inability to polarize lytic granules toward the target cell. However, how DOCK8 can regulate so many critical steps in the development of NK cell killing is not known. It is our central hypothesis that the DOCK8-interactome coordinates the regulation of the actin and microtubule cytoskeletons to facilitate NK cell polarization and effect NK cellular cytotoxicity. Based on the preliminary data included in this proposal, we hypothesize that: (a) DOCK8 activation of CDC42 is critical to the development of NK cell killing; (b) DOCK8 interaction with WASP is critical for its localization and F-actin generation at the NKIS; (c) talin recruitment by DOCK8 mediates NK cell – target adhesion; (d) HkRP3, a hematopoietically expressed protein that interacts with DOCK8 is involved in MTOC polarization and lytic granule clustering and affects lytic granule clustering through its interactions with tubulin and the dynein motor complex; (e) septins are DOCK8 interacting proteins that regulate NK cell killing; (f) BORG stabilization of septin filaments is impaired by active Cdc42 in order to regulate NK cell killing. In order to test these hypotheses we will: (1) Determine the mechanism by which DOCK8 regulates F-actin dynamics and cell adhesion; (2) Define the mechanism by which HkRP3 regulates lytic granule convergence and MTOC polarization; (3) Determine the role of septins in the regulation of the NK cell cytotoxicity. The outcome of the proposed experiments will provide an experimental basis for understanding the molecular events that are involved in the regulation of NK cell effector functions, and will, in a broader context, advance our understanding of fundamental processes in cellular activation leading to F-actin regulation, MTOC polarization and granule exocytosis. Moreover, the information obtained through these studies will likely instruct how DOCK8 is functioning in other immune cells.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.
参与 NK 细胞溶细胞功能的质膜近端细胞步骤的分子调节。
DOI: 10.1242/jcs.240424
发表时间: 2020
期刊: Journal of cell science
影响因子: 4
作者: [Phatarpekar,PrasadV, Billadeau,DanielD]
通讯作者: Billadeau,DanielD
DOI: 10.3389/fimmu.2022.871106
发表时间: 2022
期刊: Frontiers in immunology
影响因子: 7.3
作者: []
通讯作者:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
  • 批准号:
    10593963
  • 项目类别:
  • 资助金额:
    $1.64万
  • 财政年份:
    2021
  • 负责人:
    DANIEL D BILLADEAU
  • 依托单位:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
  • 批准号:
    10095909
  • 项目类别:
  • 资助金额:
    $32.97万
  • 财政年份:
    2021
  • 负责人:
    DANIEL D BILLADEAU
  • 依托单位:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
  • 批准号:
    10378472
  • 项目类别:
  • 资助金额:
    $32.31万
  • 财政年份:
    2021
  • 负责人:
    DANIEL D BILLADEAU
  • 依托单位:
海外基金